Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, double-blind, placebo-controlled multicenter trial

Gastrointestinal Endoscopy

Volumn 69, Issue 6, 2009, Pages

  Nøjgaard, Camilla ^a   Hornum, Mads ^a   Elkjaer, Margarita ^a   Hjalmarsson, Claes ^a   Heyries, Laurent ^a   Hauge, Truls ^a   Bakkevold, Kåre ^a   Andersen, Per Kragh ^a   Matzen, Peter ^a  

^a HAUGESUND HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DISCOTRINE; GLUCAGON; GLYCERYL TRINITRATE; MORPHINE; PLACEBO; PROPOFOL; SCOPOLAMINE BUTYL BROMIDE; SUFENTANIL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILE DUCT STONE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GENERAL ANESTHESIA; HEADACHE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY; PANCREATITIS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PANCREATITIS, ACUTE NECROTIZING; RISK; VASODILATOR AGENTS; YOUNG ADULT;

EID: 65449121981     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2008.11.042     Document Type: Article

References (23)

1. Freeman M.L. Post-ERCP pancreatitis: patient and technique-related risk factors. JOP 3 (2002) 169-176
2. Andriulli A., Clemente R., Solmi L., et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 56 (2002) 488-495
3. Andriulli A., Solmi L., Loperfido S., et al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol 2 (2004) 713-718
4. Li Z.S., Pan X., Zhan W.J., et al. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol 102 (2007) 46-51
5. Manes G., Ardizzone S., Lombardi G., et al. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized controlled multicenter study. Gastrointest Endosc 65 (2007) 982-987
6. Murray B., Carter R., Imrie C., et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 124 (2003) 1786-1791
7. Sotoudehmanesh R., Khatibian M., Kolahdoozan S., et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol 102 (2007) 978-983
8. Dumot J.A., Conwell D.L., Zuccaro Jr. G., et al. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol 96 (2001) 2098-2102
9. Devière J., Le Moine O., Van Laethem J.L., et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 120 (2001) 498-505
10. Sand J., and Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after therapeutic endoscopic retrograde cholangiopancreatography. Digestion 54 (1993) 105-111
11. Moretó M., Zaballa M., Casado I., et al. Transdermal glyceryl nitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 57 (2003) 1-7
12. Sudhindran S., Bromwich E., and Edwards P.R. Prospective randomized double-blind placebo-controlled trial of glyceryl nitrate in therapeutic endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 88 (2001) 1178-1182
13. Harrison L.I., Riedel J.L., Machacek J.H., et al. Bioequivalence comparison of two drug-in-adhesive transdermal nitroglycerin patches. Am J Ther 3 (1996) 580-585
14. Bradley III E.L. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 128 (1993) 586-590
15. Cotton P.B., Lehman G., Vennes J., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37 (1991) 383-393
16. Testoni P.A. Preventing post-ERCP pancreatitis: where are we?. JOP 4 (2003) 22-32
17. Pande H., and Thuluvath P.J. Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Drugs 63 (2003) 1799-1812
18. Freeman M.I. Prevention of post-ERCP pancreatitis: pharmacologic solution or patient selection and pancreatic stents?. Gastroenterology 124 (2003) 1977-1980
19. Williams E.J., Taylor S., Fairclough P., et al. Risk factors for complication following ERCP: results of a large-scale, prospective multicenter study. Endoscopy 39 (2007) 793-801
20. Demols A., and Deviere J. New frontiers in the pharmacological prevention of post-ERCP pancreatitis: the cytokines. JOP 4 (2003) 49-57
21. Mariani A. Pharmacological prevention of post-ERCP pancreatitis: which therapy is best?. JOP 4 (2003) 68-74
22. Kaffes A.J., Bourke M.J., Ding S., et al. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc 64 (2006) 351-357
23. Barrioz T., Beauchant M., and French Multicenter Group. Intravenous nitroglycerine for the prevention of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography: a randomised, double blind, placebo controlled multicenter trial. Endoscopy 55 V Suppl (2006) A24 OP-G-101